Diabetes Insipidus After Endoscopic Transsphenoidal Surgery.

Abstract

Diabetes insipidus (DI) is a recognized transient or permanent complication following transsphenoidal surgery (TSS) for pituitary tumors. To describe significant experience with the incidence of DI after TSS, identifying predictive characteristics and describing our diagnosis and management of postoperative DI. A retrospective analysis was performed of 700 patients who underwent endoscopic TSS for resection of pituitary adenoma (PA), Rathke cleft cyst (RCC), or craniopharyngioma. Inclusion criteria included at least 1 wk of follow-up for diagnosis of postoperative DI. Permanent DI was defined as DI symptoms and/or need for desmopressin more than 1 yr postoperatively. All patients with at least 1 yr of follow-up (n=345) were included in analyses of permanent DI. Multivariable logistic regression models were constructed to identify predictors of transient or permanent postoperative DI. The overall rate of any postoperative DI was 14.7% (103/700). Permanent DI developed in 4.6% (16/345). The median follow-up was 10.7 mo (range: 0.2-136.6). Compared to patients with PA, patients with RCC (odds ratio [OR]=2.2, 95% CI: 1.2-3.9; P=.009) and craniopharyngioma (OR=7.0, 95% CI: 2.9-16.9; P≤.001) were more likely to develop postoperative DI. Furthermore, patients with RCC (OR=6.1, 95% CI: 1.8-20.6; P=.004) or craniopharyngioma (OR=18.8, 95% CI: 4.9-72.6; P≤.001) were more likely to develop permanent DI compared to those with PA. Although transient DI is a relatively common complication of endoscopic and microscopic TSS, permanent DI is much less frequent. The underlying pathology is an important predictor of both occurrence and permanency of postoperative DI.